Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence
Crossref DOI link: https://doi.org/10.1186/s13737-016-0030-7
Published Online: 2016-01-20
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Castellaneta, Antonino
Massaro, Antonio
Rendina, Maria
D’Errico, Francesca
Carparelli, Sonia
Rizzi, Salvatore Fabio
Thomson, Angus W.
Di Leo, Alfredo
Funding for this research was provided by:
Ministero della Salute (Grant 177/GR-2010.2320236)
Rottapharm (LEG-SIL-LTX-02)
